135 related articles for article (PubMed ID: 2498102)
1. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
Kavi J; Stone J; Andrews JM; Ashby JP; Wise R
Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.
Leigh DA; Harris C; Tait S; Walsh B; Hancock P
J Antimicrob Chemother; 1991 May; 27(5):655-62. PubMed ID: 1885423
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and safety of single oral doses of lomefloxacin.
Morse IS
Biopharm Drug Dispos; 1990; 11(6):543-51. PubMed ID: 2207304
[TBL] [Abstract][Full Text] [Related]
5. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
Bergogne-Bérézin E; Muller-Serieys C; Kafé H
Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
[TBL] [Abstract][Full Text] [Related]
6. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
Mant TG
Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
Morrison PJ; Mant TG; Norman GT; Robinson J; Kunka RL
Antimicrob Agents Chemother; 1988 Oct; 32(10):1503-7. PubMed ID: 3214495
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lomefloxacin in healthy volunteers: comparison of 400 milligrams once daily and 200 milligrams twice daily given orally for 5 days.
Gros I; Carbon C
Antimicrob Agents Chemother; 1990 Jan; 34(1):150-2. PubMed ID: 2327750
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.
Wise R; Johnson J; O'Sullivan N; Andrews JM; Imbimbo BP
J Antimicrob Chemother; 1991 Dec; 28(6):905-9. PubMed ID: 1667783
[TBL] [Abstract][Full Text] [Related]
10. Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
Stuht H; Lode H; Koeppe P; Rost KL; Schaberg T
Antimicrob Agents Chemother; 1995 May; 39(5):1045-9. PubMed ID: 7625786
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of lomefloxacin in renally compromised patients.
Blum RA; Schultz RW; Schentag JJ
Antimicrob Agents Chemother; 1990 Dec; 34(12):2364-8. PubMed ID: 2088191
[TBL] [Abstract][Full Text] [Related]
12. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
[TBL] [Abstract][Full Text] [Related]
13. A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose.
Wise R; Andrews JM; Ashby JP; Marshall J
J Antimicrob Chemother; 1999 Nov; 44(5):701-4. PubMed ID: 10552990
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and safety of lomefloxacin following multiple doses.
Hunt TL; Adams MA
Diagn Microbiol Infect Dis; 1989; 12(2):181-7. PubMed ID: 2752716
[TBL] [Abstract][Full Text] [Related]
15. Lomefloxacin clinical pharmacokinetics.
Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
Clin Pharmacokinet; 1993 Jul; 25(1):6-19. PubMed ID: 8394795
[TBL] [Abstract][Full Text] [Related]
16. Single-dose pharmacokinetics and penetration of BMS 284756 into an inflammatory exudate.
Wise R; Gee T; Marshall G; Andrews JM
Antimicrob Agents Chemother; 2002 Jan; 46(1):242-4. PubMed ID: 11751144
[TBL] [Abstract][Full Text] [Related]
17. Intraprostatic distribution of lomefloxacin following multiple-dose administration.
Kovarik JM; de Hond JA; Hoepelman IM; Boon T; Verhoef J
Antimicrob Agents Chemother; 1990 Dec; 34(12):2398-401. PubMed ID: 2088193
[TBL] [Abstract][Full Text] [Related]
18. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
Wijnands GJ; Cornel JH; Martea M; Vree TB
Chest; 1990 Dec; 98(6):1440-4. PubMed ID: 2245687
[TBL] [Abstract][Full Text] [Related]
19. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
Nye K; Shi YG; Andrews JM; Ashby JP; Wise R
J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and inflammatory fluid penetration of clinafloxacin.
Wise R; Jones S; Das I; Andrews JM
Antimicrob Agents Chemother; 1998 Feb; 42(2):428-30. PubMed ID: 9527799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
